Thrive Wealth Management »

Beam Therapeutics shares owned by Thrive Wealth Management

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Thrive Wealth Management from 13F filings

Historical chart of Thrive Wealth Management investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Thrive Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Thrive Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $229k 6.9k 33.04

More positions owned by Thrive Wealth Management

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Index Fds Value Etf (VTV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Intl Eqty Factor (INTF)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Apple (AAPL)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Small Cp Etf (VB)
Johnson & Johnson (JNJ)
Ishares Tr Msci Intl Qualty (IQLT)

View all positions for Thrive Wealth Management

Top funds holding Beam Therapeutics

ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Redmile Group
Yiheng Capital
Baillie Gifford & Co
Bellevue Group
Charles Schwab Investment Management
Dimensional Fund Advisors
Casdin Capital
Jpmorgan Chase & Co
Goldman Sachs Group
Tang Capital Management
Jane Street

View all funds holding Beam Therapeutics